Interestingly, this pathway seems to have different roles in different DC subtypes, as deletion of Atg16l1 in CD8α+ DCs did not affect the development of atherosclerosis compared to CD11b+ DCs. This evidence concerns the gene ATG16L1 and atherosclerosis.